Претраживање
Приказ резултата 1-10 од 94
Inhibitors of tumor necrosis factor-α and mechanisms of their action / Inhibitori faktora nekroze tumora–α i mehanizmi njihovog dejstva
(Beograd : Savez farmaceutskih udruženja Srbije, 2020)
Tumor necrosis factor (TNF)-α is a proinflammatory cytokine with a role in immunity to pathogens, as well as in the pathogenesis of several autoimmune/inflammatory diseases. Biological drugs targeting this cytokine and ...
Chaotropic effect of trifluoroacetic and perchloric acid on β-cyclodextrininclusion complexation process with risperidone, olanzapine and their selected impuritiesN / Haotropni efekat trifluorosirćetne i perhlorne kiseline na formiranje inkluzionih kompleksa između β-ciklodekstrina irisperidona, olanzapinainjihovih srodnih supstanci
(Beograd: Savez farmaceutskih udruženja Srbije, 2020)
Effective method development together with method`s eco-friendly character are gaining importance in drug analyses nowadays. One of the strategies often applied to improve the efficacy of separation methods, especially in ...
Direct oral anticoagulants – a new chapter in anticoagulation therapy / Direktni oralni antikoagulansi - novo poglavlje u antikoagulantnoj terapiji
(Beograd : Savez farmaceutskih udruženja Srbije, 2020)
Thromboembolic events are the leading cause of morbidity and mortality worldwide. From the second half of the 20th century, vitamin K antagonists (VKAs), warfarin and acenocoumarol, were the only anticoagulants taken orally. ...
Chemometric window to antimicrobial activity of biomolecules isolated from endophytic fungi / Hemometrijski prozor ka antibakterijskoj aktivnosti biomolekula izolovanih iz endofitnih gljiva
(Pharmaceutical Association of Serbia, 2020)
Drug resistance, especially bacterial antibiotic resistance, is recognized as a global phenomenon. Potential of endophytic fungi as producers of secondary metabolites with wide spectra of different bioactivities in the ...
The current place of direct oral anticoagulants in the prevention/treatment of venous thromboembolism / Mesto direktnih oralnih antikoagulansa u prevenciji/lečenju venskog tromboembolizma
(Beograd : Savez farmaceutskih udruženja Srbije, 2020)
Venous thromboembolism (VTE; includes deep venous thrombosis, DVT, and pulmonary embolism, PE) represents the third most common acute cardiovascular syndrome. Contemporary VTE management comprises primary prevention in ...
The emerging role of physiologically-based pharmacokinetic/biopharmaceutics modeling in formulation development / Uloga fiziološki-zasnovanog farmakokinetičkog/biofarmaceutskog modelovanja u razvoju farmaceutskih preparata
(Beograd : Savez farmaceutskih udruženja Srbije, 2021)
Computer-based (in silico) modeling & simulation tools have been embraced in different
fields of pharmaceutics for a variety of applications. Among these, physiologically-based
pharmacokinetic/biopharmaceutics modeling ...
Experimental design in HPLC separation of pharmaceuticals / Primena eksperimentalnog dizajna za razdvajanje lekova HPLC metodom
(Beograd : Savez farmaceutskih udruženja Srbije, 2021)
Design of Experiments (DoE) is an indispensable tool in contemporary drug analysis as it
simultaneously balances a number of chromatographic parameters to ensure optimal separation
in High Pressure Liquid Chromatography ...
Current computer-aided drug design methodologies in discovery of novel drug candidates for neuropsychiatric and inflammatory diseases / Metode kompjuterski potpomognutog dizajniranja lekova u istraživanju novih potencijalnih terapeutika za neuropsihijatrijske i inflamatorne bolesti
(Beograd : Savez farmaceutskih udruženja Srbije, 2021)
Drug discovery and development is a very challenging, expensive and time-consuming
process. Impressive technological advances in computer sciences and molecular biology have
made it possible to use computer-aided drug ...
Relevance and evaluation of the benchmark dose in toxicology / Značaj i procena benchmark doze u toksikologiji
(Beograd : Savez farmaceutskih udruženja Srbije, 2020)
This paper aims to present the importance of the benchmark dose (BMD) as a point of departure (the lowest dose or concentration in the experiment that deviates from the response that differs from the normal ...
Development and validation of a stability- indicating RP-HPLC method for determination of aripiprazole and its degradation products / Razvoj i validacija RP-HPLC metode za praćenje stabilnosti u cilju određivanja sadržaja aripiprazola i njegovih degradacionih proizvoda
(Savez farmaceutskih udruženja Srbije (SFUS), 2023)
The goal of this study was the optimization of chromatographic conditions and validation
of the isocratic RP-HPLC method for monitoring the stability of aripiprazole, identification and
quantitative analysis of aripiprazole ...